KFDA to switch its penalty regulations to heavier fines

The Korea Food and Drug Administration unveiled its plan that those who will be found to violate the current Pharmaceutical Affairs Law should be subject to heavier fines as implemented in advanced countries instead of business suspension, as the administrative dispositions focusing on as business suspension is deemed ineffective

To that end, the health agency added that the ceiling amount ...